about
Increased inflammatory activity in nonobese patients with coronary artery disease and obstructive sleep apnea.Long-term secondary prevention of acute myocardial infarction (SEPAT) - guidelines adherence and outcome.Association between left atrial enlargement and obstructive sleep apnea in a general population of 71-year-old men.Optimizing the Management of Heart Failure With Preserved Ejection Fraction in the Elderly by Targeting Comorbidities (OPTIMIZE-HFPEF).Effect of Positive Airway Pressure on Cardiovascular Outcomes in Coronary Artery Disease Patients with Nonsleepy Obstructive Sleep Apnea. The RICCADSA Randomized Controlled Trial.Obstructive sleep apnea is independently associated with worse diastolic function in coronary artery disease.CPAP does not reduce inflammatory biomarkers in patients with coronary artery disease and nonsleepy obstructive sleep apnea: a randomized controlled trial.Occurrence and predictors of obstructive sleep apnea in a revascularized coronary artery disease cohort.Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.Outcomes in coronary artery disease patients with sleepy obstructive sleep apnoea on CPAP.Effect of CPAP on diastolic function in coronary artery disease patients with nonsleepy obstructive sleep apnea: A randomized controlled trial.Neuroendocrine and Inflammatory Responses to Losartan and Continuous Positive Airway Pressure in Patients with Hypertension and Obstructive Sleep Apnea. A Randomized Controlled Trial.Blood Pressure Response to Losartan and Continuous Positive Airway Pressure in Hypertension and Obstructive Sleep Apnea.Larger right atrium than left atrium is associated with all-cause mortality in elderly patients with heart failure.Answer to Dr. EyubogluDeterminants of depressive mood in coronary artery disease patients with obstructive sleep apnea and response to continuous positive airway pressure treatment in non-sleepy and sleepy phenotypes in the RICCADSA cohortContinuous Positive Airway Pressure Treatment and Depression in Adults with Coronary Artery Disease and Nonsleepy Obstructive Sleep Apnea. A Secondary Analysis of the RICCADSA Trial
P50
Q35104900-18AF7F8E-B1C0-4C69-8D6C-0ECEAB76FB7AQ36195380-69184066-0813-42D0-A23B-DDE4FC6A84A9Q38610817-3997F962-43D0-4AD7-ABCF-1C68A96D03D2Q40049700-CC112B33-B4E8-4C30-86D6-CCA54C213529Q40888290-0A5FF9C3-9508-413A-A311-A5EDFF9FA4B0Q41641747-06F25D85-9619-40C7-ABB1-A5E29054C528Q42696823-990BA367-E406-4A1C-BEB2-330E43145A12Q43632487-DEDBBBA6-E84E-473A-8910-E273ADC089C4Q47582958-3228C9FF-D32F-4533-9CDC-DDC437E4B2C9Q47656070-6212C17F-BE45-4480-96E5-01A3B1AF161EQ47742191-71855A7D-C0C6-4FD1-9725-CACB1F11256CQ47823437-59DE0D77-D1B4-4A2C-93B1-481ACC5F12BCQ47932802-AD98C07C-E014-4FB5-87AE-6E9E5A62A39EQ48124795-195A0FC0-45EA-4A20-A468-31F7135A60DBQ87669969-AFE7CB34-94B0-4447-82EB-77351AE517E2Q90976453-662497DB-BC0C-45CC-8D18-1CA071A3AE3AQ91063239-AD78A720-38D8-433D-9CDA-3BD63B7FC924
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Erik Thunström
@ast
Erik Thunström
@en
Erik Thunström
@es
Erik Thunström
@nl
type
label
Erik Thunström
@ast
Erik Thunström
@en
Erik Thunström
@es
Erik Thunström
@nl
prefLabel
Erik Thunström
@ast
Erik Thunström
@en
Erik Thunström
@es
Erik Thunström
@nl
P106
P31
P496
0000-0002-9134-2107